{"count": 2, "results": [{"_id": "35096812", "pmid": 35096812, "pmcid": "PMC8793072", "title": "Diabetes Medication Metformin Inhibits Osteoclast Formation and Activity in In Vitro Models for Periodontitis", "journal": "Front Cell Dev Biol", "authors": ["Tao LY", "Łagosz-Ćwik KB", "Hogervorst JMA", "Schoenmaker T", "Grabiec AM", "Forouzanfar T", "van der Weijden FA", "de Vries TJ"], "date": "2022-01-13T00:00:00Z", "doi": "10.3389/fcell.2021.777450", "meta_date_publication": "2021", "meta_volume": "9", "meta_issue": "", "meta_pages": "777450", "score": 50248.273, "text_hl": "In parallel to decreased osteoclast formation on bone slices, bone @<m>DISEASE_Tooth_Resorption</m> @DISEASE_MESH:D014091 @@@resorption@@@ was abolished at 1.0 mM @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ (Figure 4H).", "citations": {"NLM": "Tao LY, Łagosz-Ćwik KB, Hogervorst JMA, Schoenmaker T, Grabiec AM, Forouzanfar T, van der Weijden FA, de Vries TJ. Diabetes Medication Metformin Inhibits Osteoclast Formation and Activity in In Vitro Models for Periodontitis Front Cell Dev Biol. 2021;9():777450. PMID: 35096812", "BibTeX": "@article{35096812, title={Diabetes Medication Metformin Inhibits Osteoclast Formation and Activity in In Vitro Models for Periodontitis}, author={Tao LY and Łagosz-Ćwik KB and Hogervorst JMA and Schoenmaker T and Grabiec AM and Forouzanfar T and van der Weijden FA and de Vries TJ}, journal={Front Cell Dev Biol}, volume={9}, pages={777450}}"}}, {"_id": "22703658", "pmid": 22703658, "title": "Protective effect of metformin on periapical lesions in rats by decreasing the ratio of receptor activator of nuclear factor kappa B ligand/osteoprotegerin.", "journal": "J Endod", "authors": ["Liu L", "Zhang C", "Hu Y", "Peng B"], "date": "2012-07-01T00:00:00Z", "doi": "10.1016/j.joen.2012.03.010", "meta_date_publication": "2012 Jul", "meta_volume": "38", "meta_issue": "7", "meta_pages": "943-7", "score": 50053.8, "text_hl": "CONCLUSIONS: @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ inhibits the @DISEASE_Periapical_Diseases @DISEASE_MESH:D010483 @@@periapical lesions@@@ possibly by lowering the @GENE_TNFSF11 @GENE_117516 @@@RANKL@@@/@GENE_TNFRSF11B @GENE_25341 @@@OPG@@@ ratio, subsequently reducing the number of osteoclasts and bone @<m>DISEASE_Tooth_Resorption</m> @DISEASE_MESH:D014091 @@@resorption@@@ areas.", "citations": {"NLM": "Liu L, Zhang C, Hu Y, Peng B. Protective effect of metformin on periapical lesions in rats by decreasing the ratio of receptor activator of nuclear factor kappa B ligand/osteoprotegerin. J Endod. 2012 Jul;38(7):943-7. PMID: 22703658", "BibTeX": "@article{22703658, title={Protective effect of metformin on periapical lesions in rats by decreasing the ratio of receptor activator of nuclear factor kappa B ligand/osteoprotegerin.}, author={Liu L and Zhang C and Hu Y and Peng B}, journal={J Endod}, volume={38}, number={7}, pages={943-7}}"}}]}